A 32-year-old primigravida at 18 weeks gestation presents for routine antenatal screening. Transabdominal ultrasound shows a single cystic lesion in the fetal abdomen with internal echoes, no peristalsis, and mild polyhydramnios. The lesion does not communicate with the bladder or bowel on real-time imaging. What is the investigation of choice to confirm the diagnosis and assess for associated anomalies?

Explanation

## Clinical Context The clinical presentation—a cystic abdominal lesion with internal echoes, no peristalsis, and no communication to urinary or GI tract—is highly suspicious for a **meconium pseudocyst** or **enteric duplication cyst**. The presence of polyhydramnios raises concern for associated anomalies (e.g., VACTERL, cardiac defects). ## Why Fetal MRI Is the Investigation of Choice **Key Point:** Fetal MRI is the gold standard for characterizing complex intra-abdominal masses and detecting associated anomalies in the second and third trimester. ### Advantages of Fetal MRI in this scenario: 1. **Superior soft-tissue contrast** — differentiates cyst content (meconium, fluid, hemorrhage) better than ultrasound 2. **Multiplanar imaging** — assesses relationship to adjacent organs (bowel, kidney, spinal cord) without operator dependency 3. **Detects associated anomalies** — vertebral, cardiac, renal, and spinal cord anomalies are better visualized on MRI 4. **No acoustic windows required** — unlike ultrasound, maternal obesity or oligohydramnios do not limit image quality 5. **No ionizing radiation** — safe in pregnancy **High-Yield:** Fetal MRI is particularly valuable when ultrasound findings are **equivocal** or when **syndromic associations** (VACTERL, trisomy 13/18) are suspected. ## Timing and Clinical Pearls **Clinical Pearl:** Fetal MRI is most informative from **18–24 weeks onward**, when fetal size and organ maturity allow adequate visualization. At 18 weeks, the fetus is at the threshold of optimal imaging. **Key Point:** MRI does NOT replace ultrasound but **complements** it when: - Ultrasound diagnosis is uncertain - Associated anomalies need exclusion - Surgical planning requires precise anatomy ## Comparison with Other Investigations | Investigation | Role | Limitation in This Case | |---|---|---| | **Transvaginal USG + Doppler** | Improves visualization of pelvic structures; assesses placental flow | Does not improve characterization of abdominal mass; no advantage over transabdominal USG at 18 weeks | | **3D/4D USG** | Enhances spatial relationships; useful for facial/skeletal anomalies | Operator-dependent; limited by acoustic windows; does not improve soft-tissue characterization of cystic lesions | | **Postnatal CT** | Definitive diagnosis and surgical planning | Exposes neonate to ionizing radiation; diagnosis should be made prenatally for delivery planning and neonatal preparation | ## Summary Algorithm ```mermaid flowchart TD A[Fetal abdominal cystic lesion on USG]:::outcome --> B{Diagnosis clear on USG?}:::decision B -->|Yes, simple cyst| C[Serial USG monitoring]:::action B -->|No, complex/syndromic concern| D[Fetal MRI]:::action D --> E[Characterize lesion + screen for VACTERL/trisomy]:::action E --> F[Multidisciplinary counseling + delivery planning]:::action ```